Diagnosing Substance Use Disorders and Initiating Medications for Opioid Use Disorder
Outline and Key Points covered by this training includes:
- Screening for Substance Use.
- Diagnosis of Substance Use Disorders
- Medications for Opioid Use Disorder
- Methadone Initiation
- Buprenorphine Initiation
This course is designed for health care professionals including physicians, nurses, patients and caregivers, among others.
Upon completion of this activity, participants should be able to:
- Describe validated substance use screening tools and diagnosis of substance use disorders using DSM-5 criteria.
- List FDA-approved medications for treatment of opioid use disorder and understand their mechanisms of action.
- Compare efficacy of different pharmacologic treatments for opioid use disorder.
- Discuss various initiation methods for medications for opioid use disorder.
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Margaret Shang, MD - Clinical Instructor of Medicine, Division of General Internal Medicine, University of Pittsburgh. Addiction Medicine, University of Pittsburgh Medical Center
Conflict of Interest Disclosure:
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this enduring material activity for a maximum of 0.75 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
DEA Medication Access and Training Expansion (MATE) Act
This training is designed to meet the training requirements for the Medication Access and Training Expansion (MATE) Act of 2023.
Pennsylvania Opioid/Pain Management Credit (physicians only)
This activity has been designated as and qualifies for Opioid/Pain Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purpose
- 0.75 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 0.75 Opioid Education
- 0.75 Attendance
- 0.75 Opioid Education
Choose Register/Complete Course to complete the module.
First time Users: If you have never completed training on this website, please select register in the upper right hand corner of the webpage.
Returning Users: If you have completed training on this website, please log in in the upper right hand corner of the webpage.